This study shows that individual oligogenic analysis is implementable in selected patients and represents a feasible addition to monogenic analysis, and could not identify any definite oligogenic combination.
Abstract
Objective
Genetic factors contribute to the majority of epilepsies, but the exact genetic cause remains unknown in most patients. Incomplete penetrance and variable expressivity are frequent, and recent studies showed a burden of deleterious variants in epilepsy genes, suggesting a role for oligogenic inheritance. Here, we investigated both monogenic and oligogenic inheritance in a large cohort of patients with epilepsy.
Methods
We used exome data of 422 patients and 5308 nonepileptic individuals generated by the Epi25 Collaborative project. First, a stepwise monogenic analysis was performed on all patients. Next, we restricted the cases and controls to samples sequenced with the same capture kit and removed ancestry outliers using a principal component analysis approach. We performed an oligogenic analysis on this set of samples using bioinformatic tools that predict the pathogenicity of variant combinations. We used two different approaches, a cohort-based approach in 240 patients and an individual approach in six severely affected patients.
Results
Monogenic pathogenic variants were identified in 16 patients. Oligogenic cohort-based analysis identified 12 gene combinations significantly overrepresented in cases compared to controls. Individual-based analysis identified networks of variants in six patients. Manual curation of each of the variant combinations and phenotypes could not definitively confirm pathogenicity, and all combinations were finally discarded.
Significance
Although we could not identify any definite oligogenic combination, our study shows that individual oligogenic analysis is implementable in selected patients and represents a feasible addition to monogenic analysis.
The results suggest that single‐gene causes are rare in adults with TLE, consistent with previous reports indicating a low diagnostic yield of presurgical genetic testing and further support a predominantly polygenic architecture of TLE.
Antonia P. Pirker, Margot Ernst, Matias Wagner et al.· Epilepsia Open· 0 citations
This is the second report of autosomal recessive epilepsy associated with biallelic CACNB4 variants and genetic investigations play a crucial role in identifying mutation hotspots, facilitating more accurate diagnoses and enhancing the design of diagnostic panels for early detection.
The identification of novel variants enhances molecular understanding and facilitates more precise genotype-phenotype correlations, reinforcing the value of comprehensive genomic diagnostics in epilepsy management and demonstrating the clinical utility of gene panels and WES in complex phenotypes.
Renata Szalai, Á. Till, Krisztina Galimurka et al.· Human Genetics· 0 citations
This study may expand the mutation and phenotypic spectrum of SETD1A-related disorders, establishing the relationship between SETD1A variants and isolated early-onset epilepsy without accompanying severe neurodevelopmental deficits, and highlighting the value of genetic testing in infants with unexplained epilepsy.
Rina Su, Lei Zhu, Lin Jiang et al.· Frontiers in Neuroscience· 0 citations
As the first genetic study of hypertrophic cardiomyopathy in an Egyptian population, this work expands the global mutational spectrum, demonstrates the utility of genetic testing for risk stratification and personalised management, and underscores the need to diversify genomic datasets for equitable precision medicine.
Rana E Negm, R. Gabre, A. A. El‐Sherif et al.· Cardiology in the Young· 0 citations
Evidence across epilepsy subtypes is reviewed, focusing on convergence and divergence across the allelic spectrum, and how polygenic background and other modifiers may influence penetrance and clinical expressivity among carriers of rare pathogenic variants and CNVs is discussed.
Ming-Shan Cai, Hou-Rui Li, Peng Liao et al.· Frontiers in Genetics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.